The Use of Neurotoxins to Lesion Catecholamine-Containing Neurons to Model Clinical Disorders
- 1 January 1998
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 369 references indexed in Scilit:
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidasePublished by Elsevier ,2004
- Evidence for a novel neurotrophic factor for dopaminergic neurons secreted from mesencephalic glial cell linesJournal of Neuroscience Research, 1996
- Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's diseaseAnnals of Neurology, 1995
- Modulation of dopamine D1‐mediated turning behavior and striatal c‐fos expression by the substantia nigraSynapse, 1995
- Behavioral Assessment of the Effects of Embryonic Nigral Grafts in Marmosets with Unilateral 6-OHDA Lesions of the Nigrostriatal PathwayExperimental Neurology, 1994
- Levodopa Induction of Fos Immunoreactivity in Rat Brain Following Partial and Complete Lesions of the Substantia NigraExperimental Neurology, 1993
- Brain grafts and Parkinson's diseaseJournal of Cellular Biochemistry, 1991
- Induction of c‐fos and TIS genes in cultured rat astrocytes by neurotransmittersJournal of Neuroscience Research, 1989
- Oxidation of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by monoamine oxidases A and B and suicide inactivation of the enzymes by MPTPBiochemical and Biophysical Research Communications, 1984
- Evidence for a neurotrophic role of noradrenaline neurons in the postnatal development of rat cerebral cortexJournal of Neurocytology, 1982